Advancements in Predictive Medicine: MRI-Based Models for Alzheimer's Disease Outcomes
Recent advancements in predictive medicine have highlighted the integration of pharmacogenetics, clinical decision support solutions, and biomarker-driven oncology trials. A significant development in this field is the use of MRI-based predictive models for Alzheimer's disease outcomes. These models aim to predict both categorical and continuous outcomes of Alzheimer's disease using a single MRI scan, without the need for longitudinal data or additional modalities such as PET scans or genetic biomarkers. The study, conducted using data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), demonstrates the potential of these models to predict cognitive scores and disease severity. The approach leverages advanced machine learning techniques, including deep neural networks, to segment brain MRI into different tissue classes and predict cognitive outcomes. This method has shown promise in operationalizing real-world evidence within clinical workflows, potentially transforming how Alzheimer's disease is ... 
